Nanocomposite formulation system of lipid-regulating drugs based on layered double hydroxide: Synthesis, characterization and drug release properties

Pharmaceutical Research

Volumn 27, Issue 11, 2010, Pages 2394-2401

  Berber, Mohamed R ^a   Hafez, Inas H ^a   Minagawa, Keiji ^a   Mori, Takeshi ^b   Tanaka, Masami ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

controlled delivery; fibrates; formulations; LDH; nanocomposites

Indexed keywords

BEZAFIBRATE; CLOFIBRIC ACID; NANOCOMPOSITE;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIPID ANALYSIS; PRECIPITATION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SIMULATION; THERMOGRAVIMETRY; THERMOSTABILITY; X RAY POWDER DIFFRACTION;

HYPOLIPIDEMIC AGENTS; MICROSCOPY, ELECTRON, SCANNING; NANOCOMPOSITES; SPECTROPHOTOMETRY, INFRARED; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 78549278729     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0175-x     Document Type: Article

References (31)

1. WY Craig GE Palomaki JE Haddow 1989 Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data Br. Med. J. 298 784 8 1:STN:280:DyaL1M3ivFKiuw%3D%3D 10.1136/bmj.298.6676.784
2. JM Ordovas 1999 The genetics of serum lipid responsiveness to dietary interventions Proc. Nutr. Soc. 58 171 87 1:CAS:528:DyaK1MXjtlCht7g%3D 10.1079/PNS19990023 10343355 (Pubitemid 29225562)
3. J Remick H Weintraub R Setton J Offenbacher E Fisher A Schwartzbard 2008 Fibrate therapy: an update Card. Rev. 16 129 41 10.1097/CRD.0b013e31816b43d3 (Pubitemid 351549675)
4. M Ayaori Y Momiyama ZA Fayad A Yonemura R Ohmori T Kihara N Tanaka K Nakaya M Ogura S Sawada H Taniguchi M Kusuhara M Nagata H Nakamura F Ohsuzu 2008 Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia Atherosclerosis 196 425 33 1:CAS:528:DC%2BD1cXpt12htw%3D%3D 10.1016/j.atherosclerosis.2006.11.035 17196967
5. JP Emblidge ME DeLorenzo 2006 Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species Environ Res. 100 216 26 1:CAS:528:DC%2BD28Xos1ajtw%3D%3D 10.1016/j.envres.2005. 03.014 16442995 (Pubitemid 43155274)
6. DB Miller JD Spence 1998 Clinical pharmacokinetic of fibric acid derivatives (fibrates) Clin. Pharmacokinet. 34 2 155 62 1:CAS:528: DyaK1cXhsFaisrw%3D 10.2165/00003088-199834020-00003 9515185 (Pubitemid 28077673)
7. M Winkler JR Lawrence TR Neu 2001 Selective degradation of ibuprofen and clofibric acid in two model river biofilm systems Water Res. 35 3197 205 1:CAS:528:DC%2BD3MXltFOis7c%3D 10.1016/S0043-1354(01)00026-4 11487117 (Pubitemid 32664124)
8. AJ Rajeev B Luis AS Julie T Todd B Howard 2008 Effect of powder processing on performance of fenofibrate formulations Eur. J. Pharm. Biopharm. 69 727 34 10.1016/j.ejpb.2007.12.006
9. V Markus K Klaus BD Jennifer 2008 Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations Eur. J. Pharm. Biopharm. 68 283 8 10.1016/j.ejpb.2007.05.010
10. G Pol-Henri GV Michael F Diana 2004 A new fenofibrate formulation: Results of six single-dose, clinical studies of bioavailability under fed and fasting conditions Clin. Ther. 26 1456 69 10.1016/j.clinthera.2004.09.015 (Pubitemid 39582714)
11. Costantino U, Marmottini F, Nocchetti M, Vivani R. New synthetic routes to hydrotalcite-like compounds: characterisation and properties of the obtained materials. Eur. J. Inorg. Chem. 1439-1446 (1998).
12. M Ogawa H Kaiho 2002 Homogeneous precipitation of uniform hydrotalcite particles Langmuir 18 4240 2 1:CAS:528:DC%2BD38Xjt12rtb8%3D 10.1021/la0117045 (Pubitemid 35383592)
13. M Darder ML Blanco P Aranda F Leroux ER Hitzky 2005 Bio-nanocomposites based on layered double hydroxides Chem. Mater. 17 1969 77 1:CAS:528: DC%2BD2MXisVymsL0%3D 10.1021/cm0483240 (Pubitemid 40567205)
14. B Li J He DG Evans X Duan 2004 Enteric-coated layered double hydroxides as a controlled release drug delivery system Int. J. Pharm. 287 89 95 1:CAS:528:DC%2BD2cXps1OqtLg%3D 10.1016/j.ijpharm.2004.08.016 15541916 (Pubitemid 39487247)
15. J Tronto MJ Reis F Silvério VR Balbo JM Marchetti JB Valim 2004 In vitro release of citrate anions intercalated in magnesium aluminum layered double hydroxides J. Phys. Chem. 65 475 80 1:CAS:528:DC%2BD2cXmsFOgtg%3D%3D
16. L Bingxin H Jing DG Evans D Xue 2004 Inorganic layered double hydroxides as a drug delivery system: intercalation and in vitro release of fenbufen Appl. Clay Sci. 27 199 207 10.1016/j.clay.2004.07.002 (Pubitemid 39483540)
17. MR Berber K Minagawa M Katoh T Mori M Tanaka 2008 Nanocomposites of 2-arylpropionic acid drugs based on Mg-Al layered double hydroxide for dissolution enchancement Eur. J. Pharm. Sci. 35 354 60 1:CAS:528: DC%2BD1cXht1Klt7jO 10.1016/j.ejps.2008.08.006 18789388
18. S Aisawa N Higashiyama S Takahashi H Hirahara D Ikematsu H Kondo H Nakayama E Narita 2007 Intercalation behavior of L-ascorbic acid into layered double hydroxides Appl. Clay Sci. 35 146 54 1:CAS:528:DC%2BD2sXhsFKnu7s%3D 10.1016/j.clay.2006.09.003 (Pubitemid 46202041)
19. V Sokolova M Epple 2008 Inorganic nanoparticles as carriers of nucleic acids into cells Angew. Chem. Int. Ed. 47 1382 95 1:CAS:528:DC%2BD1cXisFWnu7s%3D 10.1002/anie.200703039
20. U Costantino V Ambrogi M Nocchetti L Perioli 2008 Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity Microporous Mesoporous Mat. 107 149 60 1:CAS:528:DC%2BD2sXhtlWrt7nL 10.1016/j.micromeso.2007.02.005 (Pubitemid 350102825)
21. JF White 1980 Bicarbonate-dependent chloride absorption in small intestine: Ion fluxes and intracellular chloride activities J. Membrane Biol. 53 95 107 1:CAS:528:DyaL3cXksVajsrs%3D 10.1007/BF01870578 (Pubitemid 10033414)
22. J Vatier E Malikova-Sekera MT Vitre M Mignon 1992 An artificial stomach-duodenum model for the in-vitro evaluation of antacids Aliment. Pharmacol. Ther. 6 447 58 1:CAS:528:DyaK38XlvVCiuro%3D 10.1111/j.1365-2036.1992. tb00558.x 1420737
23. - Clays Clay Miner. 23 369 70 1:CAS:528:DyaE28Xht12kurk%3D 10.1346/CCMN.1975.0230508
24. T Kuila H Acharya SK Srivastava AK Bhowmick 2007 Synthesis and characterization of ethylene vinyl acetate/Mg-Al layered double hydroxide nanocomposites J. Appl. Poly. Sci. 104 1845 51 1:CAS:528:DC%2BD2sXjs1GqtbY%3D 10.1002/app.25840 (Pubitemid 46587789)
25. Y Lin J Wang DG Evans D Li 2006 Layered and intercalated hydrotalcite-like materials as thermal stabilizers in PVC resin J. Phys. Chem. Solids 67 998 1001 1:CAS:528:DC%2BD28XlsFOnsbg%3D 10.1016/j.jpcs.2006.01.016 (Pubitemid 43850487)
26. T Lopez P Bosch M Asomoza R Gomez E Ramos 1997 DTA-TGA and FTIR spectroscopies of sol-gel hydrotalcites: Aluminum source effect on physicochemical properties Mat. Let. 31 311 6 1:CAS:528:DyaK2sXjs1Sks74%3D 10.1016/S0167-577X(96)00296-0
27. FM Labajos V Rives MA Ulibarri 1992 Effect of hydrothermal and thermal treatments on the physicochemical properties of Mg-Al hydrotalcite-like materials J. Mater. Sci. 27 1546 52 1:CAS:528:DyaK38XhvF2lsLc%3D 10.1007/BF00542916
28. S Miyata 1983 Anion exchange properties of hydrotalcite-like compounds Clays Clay Miner. 31 305 11 1:CAS:528:DyaL3sXlsVKkt7o%3D 10.1346/CCMN.1983. 0310409
29. 3 layered double hydroxides with varying the Mg/Al ratio Appl. Clay Sci 43 79 85 1:CAS:528:DC%2BD1cXhsFajsbnF 10.1016/j.clay.2008.07.005
30. M Kaneyoshi W Jones 1998 Exchange of interlayer terephthalate anions from a Mg-Al layered double hydroxide: formation of intermediate interstratified phases Chem Phys Lett 296 183 7 1:CAS:528:DyaK1cXmslSqur8%3D 10.1016/S0009-2614(98)01012-4
31. R Chitrakar S Tezuka A Sonoda K Sakane K Ooi T Hirotsu 2007 A solvent-free synthesis of Zn-Al layered double hydroxides Chem. Let. 36 446 7 1:CAS:528:DC%2BD2sXjsVSgsL8%3D 10.1246/cl.2007.446